Search

Displaying results 4791 - 4800 of 10000 in total
  1. Drug

    Maroxepin

    go.drugbank.com/drugs/DB21379
    Experimental

    Maroxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Maroxepin is a tricyclic compound. Maroxepin has a monoisotopic molecular weight of 277.15 Da.

  2. Drug

    Reclazepam

    go.drugbank.com/drugs/DB21411
    Experimental

    Reclazepam is a small molecule drug. The usage of the INN stem '-azepam' in the name indicates that Reclazepam is a diazepam derivative. Reclazepam has a monoisotopic molecular weight of 373.04 Da.

  3. Drug

    Metoxepin

    go.drugbank.com/drugs/DB21433
    Experimental

    Metoxepin is a small molecule drug. The usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.

  4. Drug

    Rizedisben

    go.drugbank.com/drugs/DB21610
    Investigational

    Rizedisben has a monoisotopic molecular weight of 519.22 Da. … Rizedisben is a small molecule drug. Rizedisben is under investigation in clinical trial NCT04983862 (Fluorescent Imaging of Nerves with Illuminare-1 During Surgery).

  5. Drug

    Davelizomib

    go.drugbank.com/drugs/DB21660
    Experimental

    Davelizomib is a small molecule drug. The usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.

  6. Drug

    Certociclib

    go.drugbank.com/drugs/DB21736
    Investigational

    Certociclib has a monoisotopic molecular weight of 365.14 Da. … Certociclib is a small molecule drug. Certociclib is under investigation in clinical trial NCT05252416 ((VELA) Study of BLU-222 in Advanced Solid Tumors).

  7. Drug

    Givosiran

    go.drugbank.com/drugs/DB15066
    Approved

    Givosiran is a small interfering RNA (siRNA) directed towards 5-aminolevulinic acid synthase, a critical enzyme in the heme biosynthesis pathway. … [L10202] Givosiran represents an important step forward in the treatment of acute hepatic porphyria as it is the first approved pharmacotherapy for the prevention of acute attacks - previous strategies

  8. Drug

    VPM1002

    go.drugbank.com/drugs/DB15801
    Investigational

    BCG versions due to the lack of the RD2 genome segment. … VPM1002 is a recombinant BCG vaccine candidate expressing listeriolysin and deficient in urease that is generated in the genetic background of BCG Prague as it has a better safety profile than some other

  9. Drug

    QR-1123

    go.drugbank.com/drugs/DB17869
    Investigational

    QR-1123 is a first-in-class investigational RNA-based oligonucleotide designed to treat autosomal dominant retinitis pigmentosa due to the P23H mutation in the rhodopsin (_RHO_) gene.[L46782]

  10. Drug

    Omberacetam

    go.drugbank.com/drugs/DB19956
    Experimental

    Omberacetam has a monoisotopic molecular weight of 318.16 Da. … Omberacetam is a small molecule drug. The usage of the INN stem '-racetam' in the name indicates that Omberacetam is a piracetam type amide type nootrope agent.